Common variants in Alzheimer’s disease and risk stratification by polygenic risk scoresItziar de Rojas, Alun Meggy, Joshua C. Bis et al.|Nature Communications|2021Cited by 345
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J. van der Lee, Estrella Morenas‐Rodríguez, EADB (Alzheimer Disease European DNA biobank) et al.|Acta Neuropathologica|2019Cited by 132
Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s diseaseNiccoló Tesi, Henne Holstege, Sven J. van der Lee et al.|Translational Psychiatry|2020Cited by 75
Centenarian controls increase variant effect sizes by an average twofold in an extreme case–extreme control analysis of Alzheimer’s diseaseNiccoló Tesi, Henne Holstege, Sven J. van der Lee et al.|European Journal of Human Genetics|2018Cited by 64
Polygenic Risk Score of Longevity Predicts Longer Survival Across an Age ContinuumNiccoló Tesi, Henne Holstege, Sven J. van der Lee et al.|The Journals of Gerontology Series A|2020Cited by 39